CD8A and cancer: The cancer immunity (CI) cycle proposed by Chen and Mellman (and recently updated (46) describes the series of stepwise events necessary for an effective anti-tumour immune response, beginning with the release of cancer neoantigens and culminating with the targeted CD8+ cytotoxic T cell mediated destruction of tumour cells.